 |
MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved an investigational new drug (IND) application to commence a pivotal Phase III registration study of...
Ozi.com.au: The New Benchmark in Australian Digital Services In a digital landscape evolving at breakneck speed, Australian businesses are demand...
Young Brisbane entrepreneurs Daniel Mikus and James Rolph, cofounders of MR Group, have been officially crowned winners of the Specialist Services...
Regional Australia Bank and Summerland Bank will proceed with a merger after members approved the move at their Annual General Meetings this week...
In a fast-moving industry defined by continuous disruption, one independent creative agency is proving that longevity and innovation can go hand i...
Deputy, the global people platform for shift-based work, has announced a new partnership with SuperAPI, marking a major enhancement to its HR pro...
KuCoin, a leading global crypto platform built on trust, announced the appointment of James Pinch as the Australian Managing Director, the establish...